Mukka Proteins Limited has submitted a regulatory disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and in accordance with SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023.
The company has received a Certificate of Registration issued by Registrar Corp, Virginia, USA. This certificate confirms the registration of the company's facility with the U.S. Food and Drug Administration (U.S. FDA). The registration is pursuant to the Federal Food Drug and Cosmetic Act, as amended by the Bioterrorism Act of 2002 and the FDA Food Safety Modernization Act.
Key Details of the Registration:
- Validity Period: The certificate is valid from its date of issuance, October 1, 2026, until December 31, 2027.
- Purpose & Impact: The registration is expected to support the company's business operations and facilitate its engagement with customers and markets that require U.S. FDA facility registration.
- Financial Impact: The disclosure states that the actual monetary or otherwise impact is "Not Applicable."
- Status: There is no withdrawal, cancellation, or suspension of the license; this field is also marked "Not Applicable."
The disclosure was signed by Mehaboobsab Mahmadgous Chalyal, Company Secretary & Compliance Officer (Membership No.: A67502), on October 27, 2026.